1. Home
  2. AEIS vs MDGL Comparison

AEIS vs MDGL Comparison

Compare AEIS & MDGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Advanced Energy Industries Inc.

AEIS

Advanced Energy Industries Inc.

HOLD

Current Price

$296.51

Market Cap

11.8B

Sector

Technology

ML Signal

HOLD

Logo Madrigal Pharmaceuticals Inc.

MDGL

Madrigal Pharmaceuticals Inc.

HOLD

Current Price

$488.93

Market Cap

11.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AEIS
MDGL
Founded
1981
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.8B
11.1B
IPO Year
1996
2005

Fundamental Metrics

Financial Performance
Metric
AEIS
MDGL
Price
$296.51
$488.93
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
11
12
Target Price
$307.73
$674.45
AVG Volume (30 Days)
948.6K
263.1K
Earning Date
05-04-2026
05-06-2026
Dividend Yield
0.11%
N/A
EPS Growth
168.53
41.32
EPS
1.58
N/A
Revenue
$453,095,000.00
$180,133,000.00
Revenue This Year
$22.53
$58.39
Revenue Next Year
$13.38
$48.55
P/E Ratio
$203.17
N/A
Revenue Growth
38.39
N/A
52 Week Low
$122.21
$275.00
52 Week High
$397.44
$615.00

Technical Indicators

Market Signals
Indicator
AEIS
MDGL
Relative Strength Index (RSI) 38.50 44.66
Support Level $292.32 $461.99
Resistance Level $350.96 $502.97
Average True Range (ATR) 17.64 20.40
MACD -1.00 -3.86
Stochastic Oscillator 12.69 48.43

Price Performance

Historical Comparison
AEIS
MDGL

About AEIS Advanced Energy Industries Inc.

Advanced Energy Industries Inc provides precision power conversion, measurement, and control solutions. The company designs, manufactures, sells, and services power electronics conversion products that transform raw electrical power into controllable, usable power for complex equipment. It operates in one reporting segment, Power Electronics Conversion Products, serving the Semiconductor Equipment, Data Center Computing, Industrial and Medical, and Telecom and Networking markets. Its products include Plasma Power Products, AC-DC Power Supply Units, DC-DC Converters, High Voltage solutions, SCR Power Controllers, and Sense and Measurement solutions. The company operates in the United States, Asia, Europe, and other regions.

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.

Share on Social Networks: